Long-term efficacy and safety of low-dose rituximab strategy in neuromyelitis optica spectrum disorder: a retrospective cohort study on treatment compliance and clinical outcomes

Long-term efficacy and safety of low-dose rituximab strategy in neuromyelitis optica spectrum disorder: a retrospective cohort study on treatment compliance and clinical outcomes

Abstract Objective To evaluate the efficacy and safety of low-dose rituximab (RTX) strategy in patients with neuromyelitis optica spectrum disorder (NMOSD) over a period exceeding 5 years and to investigate the impact of treatment compliance on clinical outcomes. Methods We conducted a retrospective...

Full description

Saved in:
Bibliographic Details
Main Authors: Yao Wang, Cong Zhao, Zonghao Pan, Rui Zhang, Yi Li, Hongzeng Li, Daidi Zhao, Jun Guo
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Low-dose
Rituximab
Compliance
Efficacy
Neuromyelitis optica spectrum disorder
Online Access:https://doi.org/10.1186/s13023-025-03770-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13023-025-03770-9

Similar Items